Free Call: 1800 792 676
R&D Eligibility Assessments
Adequately assessing a potential R&D claim at the beginning is one of the most important parts of the R&D claim process.
In Australia, there are two main R&D Tax Offsets available to companies:
- A 43.5% refundable tax offset (equivalent to a 150% deduction) to eligible entities with an aggregated turnover less than $20 million per annum.
- A 38.5% non-refundable tax offset (equivalent to 133% deduction) to eligible entities with an aggregated turnover greater than $20 million per annum.
What can I claim?
R&D activities need to meet certain legislative requirements for them to be deemed eligible ‘core’ activities by AusIndustry. The basic 3 requirements of a ‘core’ activity are illustrated in the below flowchart.
How much can I get?
| No Claim | 38.5% R&D Tax Offset | 43.5% R&D Tax Offset | |
| Assessable Income | $200 | $200 | $200 |
| Deduction/ R&D Spend | ($100) | ($100) | ($100) |
| Deductions Claimed/ Forfeited | $100 | — | — |
| Taxable Income | $100 | $200 | $200 |
| Gross Tax (30%) | (30%) | (30%) | (30%) |
| R&D Tax Credit | — | $38.50 | $43.50 |
| Net Tax Payable | ($30) | ($30) | ($30) |
| Benefit yield of R&D Spend | 8.5% | 13.5% |
Calculate your Benefit
Industry Specific Audit Issues
AusIndustry undertakes periodic reviews of R&D activities and the documentation used to substantiate those activities. The below industry specific checklists contain some of the information AusIndustry may review or request in the event an activity assessment is undertaken.
News & Research
News & Research
News & ResearchSwanson Reed – R&D Legislative Amendment Submission
The Australian Government announced a reform of the R&D Tax Incentive program as part of the 2018-19 Federal Budget. Swanson Reed is of the view that stable and generous support for R&D must be maintained to give companies confidence to […]
Neurotechnology company receives $35 million R&D funding to cure sleep problems
Dreem is a neurotechnology company that is currently working on a state of the art product which could potentially end sleeping problems and enhance people’s quality of rest during the night. The company has just been granted $35 million R&D […]
